There is concern therefore, regarding potential adverse effects related to alterations in plasma lipid patterns.7 9-12 Unfortunately, most studies of lipid tolerance have been performed after bolus injections2 3 8 or short-term infusions4 5 7 9 and it is not clear whether the results may be extrapolated to long-term infusions as used in clinical practice. As an initial step towards answering this question, plasma lipid patterns were determined in a group of normally-grown preterm neonates receiving a fat emulsion infusion continuously at a steady rate.
Parenterally administered fat emulsion particles are metabolised in a similar manner as natural chylomicrons.1 Increases in plasma lipid concentrations have been documented in low birthweight neonates receiving various doses of fat emulsions parenterally.2-9 Available data suggest that preterm neonates may not clear fat emulsion particles from their plasma as quickly as older children or adults. There is concern therefore, regarding potential adverse effects related to alterations in plasma lipid patterns.7 9-12 Unfortunately, most studies of lipid tolerance have been performed after bolus injections2 3 8 or short-term infusions4 5 7 9 and it is not clear whether the results may be extrapolated to long-term infusions as used in clinical practice. As an initial step towards answering this question, plasma lipid patterns were determined in a group of normally-grown preterm neonates receiving a fat emulsion infusion continuously at a steady rate.
Materials and methods
Ten neonates less than 1800 g were studied with their parents' consent. The study protocol was approved by the Institutional Review Board. Birthweights were recorded to the nearest 10 g. Gestational age was determined from the mother's menstrual history, checked in most cases by sonographic determination of the fetus' biparietal diameter, and confirmed by physical examination of the neonate.'3 All neonates were normally grown-that is their birthweights were between the 10th and 90th centiles for gestational maturity, gender, and race. Separate birthweight-gestational age curves were used for white Latin-American (Gibbs, unpublished data) and Anglo-American14 neonates.
The neonates were managed in accordance with our nursery's usual practices. Total parenteral nutrition was started as soon as clinically indicated. The basic regimen is shown in 10 [lI of plasma. Coefficients of variation were 9 % intra-assay and 14% inter-assay. All assays were performed in quadruplicate.
Results were analysed by comparing mean lipid concentrations at each time during infusion of lipids with the preinfusion level by the means of Student's t test. Statistical significance was defined as P value less than 0 05.
Results
The characteristics of the study subjects are shown in Table 2 . Ten neonates, 5 boys and 5 girls, were studied. Nine were of Latin-American ethic origin, and one was a white Anglo-American. Gestational ages ranged from 26 to 32 weeks; only one neonate was less than 28 weeks. Birthweights ranged from 960 to 1760 g; all but 4 neonates weighed 1200 g or less. Postnatal ages at the beginning of the study ranged from 2 to 14 days; with the exception of one, all were younger than 7 days. Six babies had hyaline membrane disease, one of whom also had an intraventricular haemorrhage, and 1 baby each had perinatal asphyxia, patent ductus arteriosus and pneumothorax, transient tachypnoea and apnoea, and necrotising enterocolitis.
Plasma lipid levels varied greatly during lipid infusion. The single 26-week-gestation neonate Preinfusion total plasma lipid concentrations averaged (mean ± SE) 327 ± 21-3 mg/100 ml (range 268-495) (Fig. 1) . While receiving only 1 g/kg a day of lipids, most values remained within the preinfusion range. Twelve hours after the start of the infusion however, the mean concentration (413 ± 16.0 mg/100 ml) was significantly higher than baseline. It remained higher thereafter. There seemed to be an increase in mean lipid concentrations after each dosage increase, but the differences between means were not statistically significant. With an infusion rate of 2 g/kg a day, most values were higher than the preinfusion range. The highest recorded concentration was 986 mg/100 ml. In contrast (Case 6) had a total lipid concentration of 1200 mg/100 ml when the infusion was stopped.
Preinfusion plasma free glycerol concentrations averaged 0-16 ± 0-098 mmol/100 ml (range 0-05-0.36) (Fig. 2) . Free glycerol thus accounted for one-third of total triglycerides, hardly a negligible fraction. During lipid infusion, free glycerol levels followed the same trend as total plasma lipids. Most values remained within the preinfusion range as long as the rate of infusion did not exceed 1 g/kg a day. Even then, 12 hours after the start of the infusion, the mean concentration (0 * 26 ± 0*093 mmol/100 ml) became significantly higher than baseline and remained higher thereafter. The highest recorded concentration was 1.01 mmol/100 ml. Interestingly, free glycerol continued to account for 28 to 44 % of total plasma triglycerides. In Case 6, free glycerol concentrations reached 2-18 mmol/100 ml. Preinfusion true plasma triglyceride concentrations averaged 0.30 ± 0.031 mmol/100 ml (range 0.18-0.33) (Fig. 3) . Four hours after the start of lipid infusion, mean levels (0-51 ± 0.04 mmol/100 ml) were already significantly higher than baseline. Mean levels at 8 and 12 hours after start of the infusion were at the upper limit of preinfusion levels, but not statistically different. Later in the study, most levels were in excess of the baseline ranges. The highest recorded concentration was 2-5 mmol/100 ml. In Case 6, true triglyceride concentrations reached 6-58 mmol/100 ml. Preinfusion free fatty acid concentrations averaged 0.41 ± 0.046 mmol/100 ml (range 0-16-0*75) (Fig. 4) . With lipid infusion rates of 1 and 2 g/kg a day, most values remained within the preinfusion range, although mean levels were significantly higher than baseline from 24 hours on. Infusion rates of 3 and 4 g/kg a day produced extremely variable free fatty acid concentrations. The highest recorded concentration was 4-31 mmol/100 ml but only 2 out of 9 neonates had levels above 1-95 mmol/l00 ml. 
